Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes.

Diabetes Care · 2012 · PMC3447831 · PMID 22851598

Europe PMC DOI

hedged sentence

0.0820

closest p · 1.6× alpha

0.0820

boldest claim

The sentences

did not reach statistical significanceP = 0.082so close (0.05 < p ≤ 0.1)

PG was also lower with IDet compared with NPH at 36 GWs, although the difference did not reach statistical significance (119.0 mg/dL [6.61 mmol/L] vs. 123 mg/dL [6.85 mmol/L]; treatment difference, –4.3 mg/dL [–0.24 mmol/L] [95% CI –9.2 to 0.5/–0.51 to 0.03]; P = 0.082).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.